Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T‐cells in the treatment of cancer has not only demonstrated the potency of utilizing T‐cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ternette, Nicola, Olde Nordkamp, Marloes J. M., Müller, Julius, Anderson, Amanda P., Nicastri, Annalisa, Hill, Adrian V. S., Kessler, Benedikt M., Li, Demin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032843/
https://www.ncbi.nlm.nih.gov/pubmed/29786170
http://dx.doi.org/10.1002/pmic.201700465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032843/
https://www.ncbi.nlm.nih.gov/pubmed/29786170
http://dx.doi.org/10.1002/pmic.201700465

Ejemplares similares